Article

Michael Fischer, MD, Discusses Non-Adherence

Michael Fischer, MD, associate professor of medicine, Harvard Medical School, associate physician, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, said that the complexity of the healthcare system is part of the challenge of managing adherence.

Michael Fischer, MD, associate professor of medicine, Harvard Medical School, associate physician, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, said that the complexity of the healthcare system is part of the challenge of managing adherence. Beyond a patient agreeing to and understanding how to take a medication, there must be coordination both with the pharmacy and the insurer.

“There are so many steps in the process and each of those is an area where we lose some patients from medication adherence,” said Dr Fischer. “Lack of understanding, maybe, of the diagnosis, lack of belief in the medications, complexity of the system, cost of the medications—each of those can be a threat to adherence, and figuring out how to address those effectively for each individual patient is really the challenge we all face at this point.”

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Ashley Yocum
Lorna Warwick
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Surbhi Sidana, MD, MBBS, Stanford University
Saad Z. Usmani, MD, MBA, FACP, FASCO, Memorial Sloan Kettering Cancer Center
EHA 2025 Congress Recap | Image Credit: Venngage
Lorna Warwick
Ashley Yocum, PhD
Dr Matthew Matasar
Dr Xavier Leleu
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo